{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:50:15Z","timestamp":1793375415393,"version":"4.5.0"},"reference-count":119,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Education Malaysia and Malaysia Medical Association","doi-asserted-by":"publisher","award":["FRGS\/1\/2018\/SKK11\/PERDANA\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2018\/SKK11\/PERDANA\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2020,9,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Antimicrobials are useful compounds intended to eradicate or stop the growth of harmful\nmicroorganisms. The sustained increase in the rates of antimicrobial resistance (AMR) worldwide\nis worrying and poses a major public health threat. The development of new antimicrobial\nagents is one of the critical approaches to overcome AMR. However, in the race towards developing\nalternative approaches to combat AMR, it appears that the scientific community is falling\nbehind when pitched against the evolutionary capacity of multi-drug resistant (MDR) bacteria. Although\nthe \u201cpioneering strategy\u201d of discovering completely new drugs is a rational approach, the time\nand effort taken are considerable, the process of drug development could instead be expedited if efforts\nwere concentrated on enhancing the efficacy of existing antimicrobials through: combination\ntherapies; bacteriophage therapy; antimicrobial adjuvants therapy or the application of\nnanotechnology. This review will briefly detail the causes and mechanisms of AMR as background,\nand then provide insights into a novel, future emerging or evolving strategies that are currently being\nevaluated and which may be developed in the future to tackle the progression of AMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570163816666190304122219","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T08:11:17Z","timestamp":1551859877000},"page":"430-447","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR"],"prefix":"10.2174","volume":"17","author":[{"given":"Chew-Li","family":"Moo","sequence":"first","affiliation":[{"name":"Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatijah","family":"Yusoff","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokrish","family":"Ajat","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pre Clinical Sciences, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 UPM, Serdang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Thomas","sequence":"additional","affiliation":[{"name":"Perdana University-Royal College of Surgeons in Ireland School of Medicine, Perdana University, MAEPS Building, Serdang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Abushelaibi","sequence":"additional","affiliation":[{"name":"Health Sciences Division, Abu Dhabi Women\u2019s College, Higher Colleges of Technology, 41012 Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swee-Hua-Erin","family":"Lim","sequence":"additional","affiliation":[{"name":"Health Sciences Division, Abu Dhabi Women\u2019s College, Higher Colleges of Technology, 41012 Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Song","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"103","volume":"52","author":"Saga T.","year":"2009","unstructured":"Saga T.; Yamaguchi K.; History of antimicrobial agents and resistant bacteria. Japan Med Assoc J 2009,52,103-108","journal-title":"Japan Med Assoc J"},{"key":"ref=2","first-page":"5","volume":"5","author":"Ellis A.","year":"2002","unstructured":"Ellis A.; Overcoming resistance. Overcoming Resist 2002,5,5-7","journal-title":"Overcoming Resist"},{"key":"ref=3","first-page":"277","volume":"40","author":"Ventola C.L.","year":"2015","unstructured":"Ventola C.L.; The antibiotic resistance crisis: part 1: causes and threats. P 2015,40(4),277-283","journal-title":"P"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s13054-014-0480-6","volume":"18","author":"Luyt C.E.","year":"2014","unstructured":"Luyt C.E.; Br\u00e9chot N.; Trouillet J.L.; Chastre J.; Antibiotic stewardship in the intensive care unit. Crit Care 2014,18(5),480","journal-title":"Crit Care"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/gmic.28027","volume":"5","author":"Viswanathan V.K.","year":"2014","unstructured":"Viswanathan V.K.; Off-label abuse of antibiotics by bacteria. Gut Microbes 2014,5(1),3-4","journal-title":"Gut Microbes"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13756-016-0101-z","volume":"5","author":"Gebretekle G.B.","year":"2016","unstructured":"Gebretekle G.B.; Serbessa M.K.; Exploration of over the counter sales of antibiotics in community pharmacies of Addis Ababa, Ethiopia: pharmacy professionals\u2019 perspective. Antimicrob Resist Infect Control 2016,5,2","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","volume":"6","author":"Ayukekbong J.A.","year":"2017","unstructured":"Ayukekbong J.A.; Ntemgwa M.; Atabe A.N.; The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 2017,6,47","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/intqhc\/8.6.519","volume":"8","author":"Goel P.K.","year":"1996","unstructured":"Goel P.K.; Ross-Degnan D.; McLaughlin T.J.; Soumerai S.B.; Influence of location and staff knowledge on quality of retail pharmacy prescribing for childhood diarrhea in Kenya. Int J Qual Health Care 1996,8(6),519-526","journal-title":"Int J Qual Health Care"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/cid\/cit070","volume":"56","author":"Bartlett J.G.","year":"2013","unstructured":"Bartlett J.G.; Gilbert D.N.; Spellberg B.; Seven ways to preserve the miracle of antibiotics. Clin Infect Dis 2013,56(10),1445-1450","journal-title":"Clin Infect Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1093\/cid\/ciu392","volume":"59","author":"Spellberg B.","year":"2014","unstructured":"Spellberg B.; Gilbert D.N.; The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis 2014,59(Suppl. 2),S71-S75","journal-title":"Clin Infect Dis"},{"key":"ref=11","first-page":"565","volume":"30","author":"Vollmer W.","year":"2005","unstructured":"Vollmer W.; Blanot D.; De Pedro M.A.; Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins. FEMS Microbiol Rev 2005,30,565-569","journal-title":"FEMS Microbiol Rev"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.07.007","volume":"Vol. 15","author":"Michalopoulos A.S.","year":"2011","unstructured":"Michalopoulos A.S.; Livaditis I.G.; Gougoutas V.;  The revival of fosfomycinInternational Journal of Infectious Diseases 2011,Vol. 15","journal-title":"The revival of fosfomycinInternational Journal of Infectious Diseases"},{"key":"ref=13","author":"Neu H.C.","year":"1996","unstructured":"Neu H.C.; Gootz T.D.;  Antimicrobial ChemotherapyBaron S Medical Microbiology 1996","journal-title":"Antimicrobial ChemotherapyBaron S Medical Microbiology"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099884","volume":"9","author":"Shahab M.","year":"2014","unstructured":"Shahab M.; Verma M.; Pathak M.; Mitra K.; Misra-Bhattacharya S.; Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi. PLoS One 2014,9(6)","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"14221","DOI":"10.1073\/pnas.0504314102","volume":"102","author":"McLuskey K.","year":"2005","unstructured":"McLuskey K.; Cameron S.; Hammerschmidt F.; Hunter W.N.; Structure and reactivity of hydroxypropylphosphonic acid epoxidase in fosfomycin biosynthesis by a cation- and flavin-dependent mechanism. Proc Natl Acad Sci USA 2005,102(40),14221-14226","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-319-40746-3_3","author":"Bhattacharjee M.K.","year":"2016","unstructured":"Bhattacharjee M.K.;  Antibiotics That Inhibit Cell Wall SynthesisChemistry of Antibiotics and Related Drugs 2016,49-94","journal-title":"Antibiotics That Inhibit Cell Wall SynthesisChemistry of Antibiotics and Related Drugs"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nrmicro3088","volume":"11","author":"Pinho M.G.","year":"2013","unstructured":"Pinho M.G.; Kjos M.; Veening J.W.; How to get (a)round: mechanisms controlling growth and division of coccoid bacteria. Nat Rev Microbiol 2013,11(9),601-614","journal-title":"Nat Rev Microbiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/antibiotics5030028","volume":"5","author":"Liu Y.","year":"2016","unstructured":"Liu Y.; Breukink E.; The membrane steps of bacterial cell wall synthesis as antibiotic targets. Antibiotics (Basel) 2016,5(3),28","journal-title":"Antibiotics (Basel)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrmicro3328","volume":"12","author":"K\u00e5hrstr\u00f6m C.T.","year":"2014","unstructured":"K\u00e5hrstr\u00f6m C.T.; Bacterial physiology: Flipping out over MurJ. Nat Rev Microbiol 2014,12(9),595","journal-title":"Nat Rev Microbiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1099\/00221287-28-3-559","volume":"28","author":"Smith J.L.","year":"1962","unstructured":"Smith J.L.; Weinberg E.D.; Mechanisms of antibacterial action of bacitracin. J Gen Microbiol 1962,28(3),559-569","journal-title":"J Gen Microbiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/1087057106294364","volume":"11","author":"Jha R.K.","year":"2006","unstructured":"Jha R.K.; de Sousa S.M.; Microplate assay for inhibitors of the transpeptidase activity of PBP1b of Escherichia coli. J Biomol Screen 2006,11(8),1005-1014","journal-title":"J Biomol Screen"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"21659","DOI":"10.1038\/srep21659","volume":"6","author":"Rioseras B.","year":"2016","unstructured":"Rioseras B.; Yag\u00fce P.; L\u00f3pez-Garc\u00eda M.T.; Characterization of SCO4439, a D-alanyl-D-alanine carboxypeptidase involved in spore cell wall maturation, resistance, and germination in Streptomyces coelicolor. Sci Rep 2016,6,21659","journal-title":"Sci Rep"},{"key":"ref=23","first-page":"4","author":"Alberts B.","year":"2002","unstructured":"Alberts B.; Johnson A.; Lewis J.; General principles of cell communication. Mol Biol Cell 2002,4","journal-title":"Mol Biol Cell"},{"key":"ref=24","first-page":"P. 73","author":"Li J.","year":"2017","unstructured":"Li J.; Koh J.J.; Liu S.; Lakshminarayanan R.; Verma C.S.; Beuerman R.W.; Membrane active antimicrobial peptides: Translating mechanistic insights to design. Frontiers Media, SA. Frontiers in Neuroscience 2017,P. 73","journal-title":"Frontiers in Neuroscience"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1517\/13543784.9.8.1731","volume":"9","author":"Bellm L.","year":"2000","unstructured":"Bellm L.; Lehrer R.I.; Ganz T.; Protegrins: new antibiotics of mammalian origin. Expert Opin Investig Drugs 2000,9(8),1731-1742","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.apsb.2014.06.012","volume":"4","author":"Hong W.","year":"2014","unstructured":"Hong W.; Zeng J.; Xie J.; Antibiotic drugs targeting bacterial RNAs. Acta Pharm Sin B 2014,4(4),258-265","journal-title":"Acta Pharm Sin B"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.20506\/rst.31.1.2095","volume":"31","author":"Lambert T.","year":"2012","unstructured":"Lambert T.; Antibiotics that affect the ribosome. Rev - Off Int Epizoot 2012,31(1),57-64","journal-title":"Rev - Off Int Epizoot"},{"key":"ref=28","author":"Kotra LP","year":"2000","unstructured":"Kotra LP; Haddad J; Mobashery S; Aminoglycosides: Perspectives\n on mechanisms of action and resistance and strategies to counter\n  re-sistance Antimicrobial Agents and Chemotherapy American Society\n  for Microbiology. ASM 2000; pp. 3249-56. 2000"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/ijms16010321","volume":"16","author":"Chopra S.","year":"2014","unstructured":"Chopra S.; Reader J.; tRNAs as antibiotic targets. Int J Mol Sci 2014,16(1),321-349","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"Chopra I.","year":"2001","unstructured":"Chopra I.; Roberts M.; Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001,65(2),232-260","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=31","author":"Constable P.D.","year":"2016","unstructured":"Constable P.D.; Hinchcliff K.W.; Kenneth W.; Done S.H.; Gr\u00fcnberg W.; Radostits O.M.;  Veterinary medicine\u202f: a textbook of the diseases of cattle, horses, sheep, pigs and goats 2016","journal-title":"Veterinary medicine\u202f: a textbook of the diseases of cattle, horses, sheep, pigs and goats"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","volume":"11","author":"Odds F.C.","year":"2003","unstructured":"Odds F.C.; Brown A.J.P.; Gow N.A.R.; Antifungal agents: mechanisms of action. Trends Microbiol 2003,11(6),272-279","journal-title":"Trends Microbiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1074\/jbc.M116.715615","volume":"291","author":"Vodnala M.","year":"2016","unstructured":"Vodnala M.; Ranjbarian F.; Pavlova A.; de Koning H.P.; Hofer A.; Trypanosoma brucei methylthioadenosine phosphorylase protects the para-site from the antitrypanosomal effect of deoxyadenosine: Implications for the pharmacology of adenosine antimetabolites. J Biol Chem 2016,291(22),11717-11726","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511545313.065","author":"Kimberlin D.W.","year":"2007","unstructured":"Kimberlin D.W.; Whitley R.J.;  Antiviral therapy of HSV-1 and -2Campadelli-Fiume G, Mocarski E, et al Human Herpesvirus-es: Biology, Therapy, and Immunoprophylaxis 2007","journal-title":"Antiviral therapy of HSV-1 and -2Campadelli-Fiume G, Mocarski E, et al Human Herpesvirus-es: Biology, Therapy, and Immunoprophylaxis"},{"key":"ref=35","first-page":"861","author":"Parenti F.","year":"2011","unstructured":"Parenti F.; Lancini G.;  Antibiotic and Chemotherapy Rifamycins 2011,861-900","journal-title":"Antibiotic and Chemotherapy Rifamycins"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","volume":"92","author":"Collin F.","year":"2011","unstructured":"Collin F.; Karkare S.; Maxwell A.; Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol 2011,92(3),479-497","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=37","first-page":"60","volume":"2016","author":"Bhattacharjee M.K.","year":"2016","unstructured":"Bhattacharjee M.K.; Chemistry of Antibiotics and Related Drugs. Springer International Publishing 2016,2016,60-94","journal-title":"Springer International Publishing"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/infdis\/128.Supplement_3.S433","volume":"128","author":"Hitchings G.H.","year":"1973","unstructured":"Hitchings G.H.; Mechanism of action of trimethoprim-sulfamethoxazole. I. J Infect Dis 1973,128,433-436","journal-title":"J Infect Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.bmc.2010.12.003","volume":"19","author":"Qi J.","year":"2011","unstructured":"Qi J.; Virga K.G.; Das S.; Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes. Bioorg Med Chem 2011,19(3),1298-1305","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"Blair J.M.A.","year":"2015","unstructured":"Blair J.M.A.; Webber M.A.; Baylay A.J.; Ogbolu D.O.; Piddock L.J.V.; Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015,13(1),42-51","journal-title":"Nat Rev Microbiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/AAC.00906-09","volume":"54","author":"Liu A.","year":"2010","unstructured":"Liu A.; Tran L.; Becket E.; Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother 2010,54(4),1393-1403","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jac\/dks373","volume":"68","author":"Blake K.L.","year":"2013","unstructured":"Blake K.L.; O\u2019Neill A.J.; Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents. J Antimicrob Chemother 2013,68(1),12-16","journal-title":"J Antimicrob Chemother"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrmicro2382","volume":"8","author":"Wozniak R.A.F.","year":"2010","unstructured":"Wozniak R.A.F.; Waldor M.K.; Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat Rev Microbiol 2010,8(8),552-563","journal-title":"Nat Rev Microbiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijantimicag.2012.08.010","volume":"41","author":"Baroud M.","year":"2013","unstructured":"Baroud M.; Dandache I.; Araj G.F.; Underlying mechanisms of carbapenem resistance in extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents 2013,41(1),75-79","journal-title":"Int J Antimicrob Agents"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","volume":"4","author":"Munita J.M.","year":"2016","unstructured":"Munita J.M.; Arias C.A.; Unit A.R.; De Santiago A.; Mechanisms of Antibiotic Resistance. Microbiol Spectr 2016,4(2),1-37","journal-title":"Microbiol Spectr"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jac\/dks357","volume":"68","author":"Dolejska M.","year":"2013","unstructured":"Dolejska M.; Villa L.; Poirel L.; Nordmann P.; Carattoli A.; Complete sequencing of an IncHI1 plasmid encoding the carbapenemase NDM-1, the ArmA 16S RNA methylase and a resistance-nodulation-cell division\/multidrug efflux pump. J Antimicrob Chemother 2013,68(1),34-39","journal-title":"J Antimicrob Chemother"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","volume":"19","author":"Piddock L.J.V.","year":"2006","unstructured":"Piddock L.J.V.; Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006,19(2),382-402","journal-title":"Clin Microbiol Rev"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature09743","volume":"470","author":"Su C.C.","year":"2011","unstructured":"Su C.C.; Long F.; Zimmermann M.T.; Rajashankar K.R.; Jernigan R.L.; Yu E.W.; Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Nature 2011,470,558-562","journal-title":"Nature"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1073\/pnas.1114944109","volume":"109","author":"Eicher T.","year":"2012","unstructured":"Eicher T.; Cha H.J.; Seeger M.A.; Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci USA 2012,109(15),5687-5692","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e00446","DOI":"10.1128\/mBio.00446-12","volume":"3","author":"Zalucki Y.M.","year":"2012","unstructured":"Zalucki Y.M.; Dhulipala V.; Shafer W.M.; Dueling regulatory properties of a transcriptional activator (MtrA) and repressor (MtrR) that control efflux pump gene expression in Neisseria gonorrhoeae. MBio 2012,3(6),e00446-e12","journal-title":"MBio"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1128\/AAC.00084-08","volume":"52","author":"Abouzeed Y.M.","year":"2008","unstructured":"Abouzeed Y.M.; Baucheron S.; Cloeckaert A.; ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2008,52(7),2428-2434","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000944","volume":"6","author":"Gao W.","year":"2010","unstructured":"Gao W.; Chua K.; Davies J.K.; Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 2010,6(6)","journal-title":"PLoS Pathog"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/1471-2164-12-512","volume":"12","author":"Billal D.S.","year":"2011","unstructured":"Billal D.S.; Feng J.; Leprohon P.; L\u00e9gar\u00e9 D.; Ouellette M.; Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. BMC Genomics 2011,12,512","journal-title":"BMC Genomics"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","volume":"44","author":"Katayama Y.","year":"2000","unstructured":"Katayama Y.; Ito T.; Hiramatsu K.; A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000,44(6),1549-1555","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pro.2424","volume":"23","author":"Kumar N.","year":"2014","unstructured":"Kumar N.; Radhakrishnan A.; Wright C.C.; Crystal structure of the transcriptional regulator Rv1219c of Mycobacterium tuberculosis. Protein Sci 2014,23(4),423-432","journal-title":"Protein Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1128\/AAC.00131-06","volume":"50","author":"Long K.S.","year":"2006","unstructured":"Long K.S.; Poehlsgaard J.; Kehrenberg C.; Schwarz S.; Vester B.; The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob Agents Chemother 2006,50(7),2500-2505","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/jac\/dkt355","volume":"69","author":"Zhang W.J.","year":"2014","unstructured":"Zhang W.J.; Xu X.R.; Schwarz S.; Characterization of the IncA\/C plasmid pSCEC2 from Escherichia coli of swine origin that harbours the multiresistance gene cfr. J Antimicrob Chemother 2014,69(2),385-389","journal-title":"J Antimicrob Chemother"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/AAC.01477-07","volume":"52","author":"Fritsche T.R.","year":"2008","unstructured":"Fritsche T.R.; Castanheira M.; Miller G.H.; Jones R.N.; Armstrong E.S.; Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother 2008,52(5),1843-1845","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"25265","DOI":"10.1074\/jbc.M111.226936","volume":"286","author":"Vetting M.W.","year":"2011","unstructured":"Vetting M.W.; Hegde S.S.; Wang M.; Jacoby G.A.; Hooper D.C.; Blanchard J.S.; Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J Biol Chem 2011,286(28),25265-25273","journal-title":"J Biol Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1517\/14656566.2013.763030","volume":"14","author":"Lynch J.P.","year":"2013","unstructured":"Lynch J.P.; Clark N.M.; Zhanel G.G.; Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum \u03b2-lactamases and carbapenemases). Expert Opin Pharmacother 2013,14(2),199-210","journal-title":"Expert Opin Pharmacother"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1128\/AAC.01004-09","volume":"54","author":"Queenan A.M.","year":"2010","unstructured":"Queenan A.M.; Shang W.; Flamm R.; Bush K.; Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob Agents Chemother 2010,54(1),565-569","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","volume":"25","author":"Tzouvelekis L.S.","year":"2012","unstructured":"Tzouvelekis L.S.; Markogiannakis A.; Psichogiou M.; Tassios P.T.; Daikos G.L.; Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012,25(4),682-707","journal-title":"Clin Microbiol Rev"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","volume":"57","author":"Wright G.D.","year":"2005","unstructured":"Wright G.D.; Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 2005,57(10),1451-1470","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5772\/67776","author":"Yap P.S.X.","year":"2017","unstructured":"Yap P.S.X.; Yang S.K.; Lai K.S.; Lim S.H.E.;  Essential Oils: The Ultimate Solution to Antimicrobial Resistance in Escherichia coli?Escherichia coli - Recent Advances on Physiology, Pathogenesis and Biotechnological Applications 2017,299-313","journal-title":"Essential Oils: The Ultimate Solution to Antimicrobial Resistance in Escherichia coli?Escherichia coli - Recent Advances on Physiology, Pathogenesis and Biotechnological Applications"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1128\/AAC.00809-12","volume":"56","author":"Qin S.","year":"2012","unstructured":"Qin S.; Wang Y.; Zhang Q.; Identification of a novel genomic island conferring resistance to multiple aminoglycoside antibiotics in Campylobacter coli. Antimicrob Agents Chemother 2012,56(10),5332-5339","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4172\/2332-0877.1000292","volume":"4","author":"Kaur I.","year":"2016","unstructured":"Kaur I.; Novel Strategies to Combat Antimicrobial Resistance. J Infect Dis Ther 2016,4,292","journal-title":"J Infect Dis Ther"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1021\/cb100269f","volume":"6","author":"Campbell J.","year":"2011","unstructured":"Campbell J.; Singh A.K.; Santa Maria J.P.; Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 2011,6(1),106-116","journal-title":"ACS Chem Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/jac\/39.suppl_1.47","volume":"39","author":"Sieradzki K.","year":"1997","unstructured":"Sieradzki K.; Tomasz A.; Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics. J Antimicrob Chemother 1997,39(Suppl. A),47-51","journal-title":"J Antimicrob Chemother"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2165\/00003495-200363140-00006","volume":"63","author":"Lee N.","year":"2003","unstructured":"Lee N.; Yuen K.Y.; Kumana C.R.; Clinical role of beta-lactam\/beta-lactamase inhibitor combinations. Drugs 2003,63(14),1511-1524","journal-title":"Drugs"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2165\/00003495-199600511-00006","volume":"51","author":"Vannuffel P.","year":"1996","unstructured":"Vannuffel P.; Cocito C.; Mechanism of action of streptogramins and macrolides. Drugs 1996,51(Suppl. 1),20-30","journal-title":"Drugs"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1128\/AAC.00922-10","volume":"54","author":"Gordon N.C.","year":"2010","unstructured":"Gordon N.C.; Png K.; Wareham D.W.; Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 2010,54(12),5316-5322","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","volume":"120","author":"De Pauw B.E.","year":"1994","unstructured":"De Pauw B.E.; Deresinski S.C.; Feld R.; Lane-Allman E.F.; Donnelly J.P.; Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. Ann Intern Med The Intercontinental Antimicrobial Study Group1994,120(10),834-844","journal-title":"Ann Intern Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0140-6736(77)91973-0","author":"Schentag JJ","year":"1977","unstructured":"Schentag JJ; Jusko WJ;  Gentamicin Persistence In The Body 1977,486","journal-title":"Gentamicin Persistence In The Body"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1128\/AAC.50.4.1213-1221.2006","volume":"50","author":"Servais H.","year":"2006","unstructured":"Servais H.; Jossin Y.; Van Bambeke F.; Tulkens P.M.; Mingeot-Leclercq M.P.; Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob Agents Chemother 2006,50(4),1213-1221","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003038.pub2","author":"Paul M","year":"2013","unstructured":"Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L;  Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia 2013","journal-title":"Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.96.5.2192","volume":"96","author":"Hendrix R.W.","year":"1999","unstructured":"Hendrix R.W.; Smith M.C.M.; Burns R.N.; Ford M.E.; Hatfull G.F.; Evolutionary relationships among diverse bacteriophages and prophages: all the world\u2019s a phage. Proc Natl Acad Sci USA 1999,96(5),2192-2197","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.4161\/bact.24219]","volume":"3","author":"Orm\u00e4l\u00e4 A.M.","year":"2013","unstructured":"Orm\u00e4l\u00e4 A.M.; Jalasvuori M.; Phage therapy: Should bacterial resistance to phages be a concern, even in the long run? Bacteriophage 2013,3(1)","journal-title":"Bacteriophage"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fmicb.2012.00238","volume":"3","author":"Keen E.C.","year":"2012","unstructured":"Keen E.C.; Phage therapy: concept to cure. Front Microbiol 2012,3,238","journal-title":"Front Microbiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0065-2164(10)70007-1","volume":"70","author":"Hyman P.","year":"2010","unstructured":"Hyman P.; Abedon S.T.; Bacteriophage host range and bacterial resistance. Adv Appl Microbiol 2010,70,217-248","journal-title":"Adv Appl Microbiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","volume":"8","author":"Chan B.K.","year":"2013","unstructured":"Chan B.K.; Abedon S.T.; Loc-Carrillo C.; Phage cocktails and the future of phage therapy. Future Microbiol 2013,8(6),769-783","journal-title":"Future Microbiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1073\/pnas.0800442106","volume":"106","author":"Lu T.K.","year":"2009","unstructured":"Lu T.K.; Collins J.J.; Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci USA 2009,106(12),4629-4634","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"e01304","DOI":"10.1128\/mBio.01304-16","volume":"7","author":"Duerkop B.A.","year":"2016","unstructured":"Duerkop B.A.; Huo W.; Bhardwaj P.; Palmer K.L.; Hooper L.V.; Molecular basis for lytic bacteriophage resistance in enterococci. MBio 2016,7(4),e01304-e01316","journal-title":"MBio"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/bact.1.2.15845","volume":"1","author":"Abedon S.T.","year":"2011","unstructured":"Abedon S.T.; Kuhl S.J.; Blasdel B.G.; Kutter E.M.; Phage treatment of human infections. Bacteriophage 2011,1(2),66-85","journal-title":"Bacteriophage"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4161\/viru.25991","volume":"5","author":"Wittebole X.","year":"2014","unstructured":"Wittebole X.; De Roock S.; Opal S.M.; A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 2014,5(1),226-235","journal-title":"Virulence"},{"key":"ref=85","first-page":"461","volume":"61","author":"Miedzybrodzki R.","year":"2007","unstructured":"Miedzybrodzki R.; Fortuna W.; Weber-Dabrowska B.; G\u00f3rski A.; Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy Hig Med Dosw 2007,61,461-465","journal-title":"Postepy Hig Med Dosw"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1128\/JB.00619-07","volume":"189","author":"Maiques E.","year":"2007","unstructured":"Maiques E.; \u00dabeda C.; Tormo M.\u00c1.; Role of staphylococcal phage and SaPI integrase in intra- and interspecies SaPI transfer. J Bacteriol 2007,189(15),5608-5616","journal-title":"J Bacteriol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/138920312804871193","volume":"13","author":"Drulis-Kawa Z.","year":"2012","unstructured":"Drulis-Kawa Z.; Majkowska-Skrobek G.; Maciejewska B.; Delattre A.S.; Lavigne R.; Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 2012,13(8),699-722","journal-title":"Curr Protein Pept Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/157489106777452692","volume":"1","author":"Van Bambeke F.","year":"2006","unstructured":"Van Bambeke F.; Pag\u00e8s J.M.; Lee V.J.; Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat Antiinfect Drug Discov 2006,1(2),157-175","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","volume":"45","author":"Lomovskaya O.","year":"2001","unstructured":"Lomovskaya O.; Warren M.S.; Lee A.; Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001,45(1),105-116","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1128\/AAC.43.7.1719","volume":"43","author":"Nelson M.L.","year":"1999","unstructured":"Nelson M.L.; Levy S.B.; Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob Agents Chemother 1999,43(7),1719-1724","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/246012","volume":"2015246012","author":"Beyth N.","year":"2015","unstructured":"Beyth N.; Houri-Haddad Y.; Domb A.; Khan W.; Hazan R.; Alternative antimicrobial approach: nano-antimicrobial materials. Evid Based Complement Alternat Med 2015,2015246012","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","volume":"65","author":"Pelgrift R.Y.","year":"2013","unstructured":"Pelgrift R.Y.; Friedman A.J.; Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev 2013,65(13-14),1803-1815","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"Wang L.","year":"2017","unstructured":"Wang L.; Hu C.; Shao L.; The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine 2017,12,1227-1249","journal-title":"Int J Nanomedicine"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.marenvres.2009.07.001","volume":"68","author":"M\u00fchling M.","year":"2009","unstructured":"M\u00fchling M.; Bradford A.; Readman J.W.; Somerfield P.J.; Handy R.D.; An investigation into the effects of silver nanoparticles on antibiotic resistance of naturally occurring bacteria in an estuarine sediment. Mar Environ Res 2009,68(5),278-283","journal-title":"Mar Environ Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"10874","DOI":"10.1021\/am403940d","volume":"5","author":"Qi G.","year":"2013","unstructured":"Qi G.; Li L.; Yu F.; Wang H.; Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells. ACS Appl Mater Interfaces 2013,5(21),10874-10881","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1073\/pnas.1107254109","volume":"109","author":"Qiu Z.","year":"2012","unstructured":"Qiu Z.; Yu Y.; Chen Z.; Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera. Proc Natl Acad Sci USA 2012,109(13),4944-4949","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1517\/17425247.2012.717927","volume":"9","author":"Sharma A.","year":"2012","unstructured":"Sharma A.; Kumar Arya D.; Dua M.; Chhatwal G.S.; Johri A.K.; Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opin Drug Deliv 2012,9(11),1325-1332","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/jfb6010104","volume":"6","author":"Azuma K.","year":"2015","unstructured":"Azuma K.; Izumi R.; Osaki T.; Chitin, chitosan, and its derivatives for wound healing: old and new materials. J Funct Biomater 2015,6(1),104-142","journal-title":"J Funct Biomater"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","volume":"156","author":"Huh A.J.","year":"2011","unstructured":"Huh A.J.; Kwon Y.J.; \u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 2011,156(2),128-145","journal-title":"J Control Release"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1359-6446(04)03276-3","volume":"10","author":"Gillies E.R.","year":"2005","unstructured":"Gillies E.R.; Fr\u00e9chet J.M.; Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005,10(1),35-43","journal-title":"Drug Discov Today"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2165\/00003495-199856050-00001","volume":"56","author":"Allen T.M.","year":"1998","unstructured":"Allen T.M.; Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs 1998,56(5),747-756","journal-title":"Drugs"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jviromet.2016.07.002","volume":"236","author":"Singla S.","year":"2016","unstructured":"Singla S.; Harjai K.; Raza K.; Wadhwa S.; Katare O.P.; Chhibber S.; Phospholipid vesicles encapsulated bacteriophage: A novel approach to enhance phage biodistribution. J Virol Methods 2016,236,68-76","journal-title":"J Virol Methods"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.2147\/IJN.S35347","volume":"7","author":"Azam A.","year":"2012","unstructured":"Azam A.; Ahmed A.S.; Oves M.; Khan M.S.; Habib S.S.; Memic A.; Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int J Nanomedicine 2012,7,6003-6009","journal-title":"Int J Nanomedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.biotechadv.2018.05.004","volume":"36","author":"M\u00f6hler J.S.","year":"2018","unstructured":"M\u00f6hler J.S.; Sim W.; Blaskovich M.A.T.; Cooper M.A.; Ziora Z.M.; Silver bullets: A new lustre on an old antimicrobial agent. Biotechnol Adv 2018,36(5),1391-1411","journal-title":"Biotechnol Adv"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jinorgbio.2016.11.028","volume":"167","author":"M\u00f6hler J.S.","year":"2017","unstructured":"M\u00f6hler J.S.; Kolmar T.; Synnatschke K.; Enhancement of antibiotic-activity through complexation with metal ions - Combined ITC, NMR, enzymatic and biological studies. J Inorg Biochem 2017,167,134-141","journal-title":"J Inorg Biochem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics10010011","volume":"10","author":"Kumar M.","year":"2018","unstructured":"Kumar M.; Curtis A.; Hoskins C.; Application of nanoparticle technologies in the combat against anti-microbial resistance. Pharmaceutics 2018,10(1),1-17","journal-title":"Pharmaceutics"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5772\/intechopen.72898","author":"Phillips M.A.","year":"2018","unstructured":"Phillips M.A.; Stewart M.A.; Woodling D.L.; Xie Z.R.;  Has Molecular Docking Ever Brought us a Medicine? 2018,141-178","journal-title":"Has Molecular Docking Ever Brought us a Medicine?"},{"key":"ref=108","first-page":"1","volume":"5","author":"Young M.J.","year":"2017","unstructured":"Young M.J.; Mahfouz T.M.; New Bacterial Targets and Computational Methods Against Bacterial Resistance. Med Res Arch 2017,5(4),1-24","journal-title":"Med Res Arch"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","volume":"14","author":"Fischbach M.A.","year":"2011","unstructured":"Fischbach M.A.; Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol 2011,14(5),519-523","journal-title":"Curr Opin Microbiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/molecules22111733","volume":"22","author":"Yang S.K.","year":"2017","unstructured":"Yang S.K.; Yusoff K.; Mai C.W.; Additivity vs synergism: Investigation of the additive interaction of cinnamon bark oil and meropenem in combinatory therapy. Molecules 2017,22(11),1733","journal-title":"Molecules"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"582","DOI":"10.25135\/rnp.59.17.12.078","volume":"12","author":"Yang S.K.","year":"2018","unstructured":"Yang S.K.; Yap P.S.X.; Krishnan T.; Mode of action: Synergistic interaction of pepper-mint (Mentha x piperita L. Carl) essential oil and meropenem against plasmid-mediated resistant E. coli. Rec Nat Prod 2018,12(6),582-594","journal-title":"Rec Nat Prod"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tibtech.2010.08.001","volume":"28","author":"Kutateladze M.","year":"2010","unstructured":"Kutateladze M.; Adamia R.; Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 2010,28(12),591-595","journal-title":"Trends Biotechnol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.00735-10","volume":"55","author":"Kalle A.M.","year":"2011","unstructured":"Kalle A.M.; Rizvi A.; Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother 2011,55(1),439-442","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.carres.2007.11.006","volume":"343","author":"Ma Y.","year":"2008","unstructured":"Ma Y.; Zhou T.; Zhao C.; Preparation of chitosan-nylon-6 blended membranes containing silver ions as antibacterial materials. Carbohydr Res 2008,343(2),230-237","journal-title":"Carbohydr Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2009.11.033","volume":"387","author":"Drulis-Kawa Z.","year":"2010","unstructured":"Drulis-Kawa Z.; Dorotkiewicz-Jach A.; Liposomes as delivery systems for antibiotics. Int J Pharm 2010,387(1-2),187-198","journal-title":"Int J Pharm"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12941-017-0216-y","volume":"16","author":"Thapa R.","year":"2017","unstructured":"Thapa R.; Bhagat C.; Shrestha P.; Awal S.; Dudhagara P.; Enzyme-mediated formulation of stable elliptical silver nanoparticles tested against clinical pathogens and MDR bacteria and development of antimicrobial surgical thread. Ann Clin Microbiol Antimicrob 2017,16(1),39","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/jcb.25929","volume":"118","author":"Shaikh S.","year":"2017","unstructured":"Shaikh S.; Rizvi S.M.D.; Shakil S.; Synthesis and characterization of cefotaxime conjugated gold nanoparticles and their use to target drug-resistant CTX-M-producing bacterial pathogens. J Cell Biochem 2017,118(9),2802-2808","journal-title":"J Cell Biochem"},{"key":"ref=118","first-page":"p. 105","author":"Mandal S.M.","year":"2014","unstructured":"Mandal S.M.; Roy A.; Ghosh A.K.; Hazra T.K.; Basak A.; Franco O.L.; Challenges and future prospects of antibiotic therapy: From peptides to phages utilization. Frontiers Media, SA. Front Pharmacol 2014,p. 105","journal-title":"Front Pharmacol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"295","DOI":"10.25135\/rnp.41.17.09.058","volume":"12","author":"Yang S.K.","year":"2018","unstructured":"Yang S.K.; Low L.Y.; Yap P.S.X.; Yusoff K.; Mai C.W.; Lai K.S.; Plant-derived antimicrobials: Insights into mitigation of antimicrobial re-sistance. Rec Nat Prod 2018,12(4),295-316","journal-title":"Rec Nat Prod"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/170403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/170403\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/170403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T10:17:39Z","timestamp":1609755459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/170403\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,9,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163816666190304122219","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}